Cullinan Therapeutics, Inc. Common Stock CGEM
$16.87
-22.15%
at last close
Financials (TTM)
- Revenue
- —
- Net Income
- $-204,688,000
- Net Margin
- —
- Return on Equity
- -63.62%
- Debt-to-Equity
- —
- P/E Ratio
- —
- Price / Book
- 4.33
- Price / Sales
- —
Over the trailing twelve months, Cullinan Therapeutics, Inc. Common Stock generated revenue of — and net income of $-204,688,000.
Key Stats
- Last Close
- $16.87
- Market Cap
- $1.39 billion
- 52-Week Range
- $5.68 – $23.19
- Average Volume
- 951K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.